SCHEMBL21233231

SCHEMBL21233231

CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(N)=O)C(=O)NO

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 2/20 0.40
▸ DPP8 Q6V1X1 2/20 0.40
▸ DPP9 Q86TI2 2/20 0.40
▸ DPP7 Q9UHL4 2/20 0.40
▸ FAP Q12884 1/20 0.38
▸ ECE1 P42892 1/20 0.38
▸ MMP8 P22894 1/20 0.38
▸ ADAM10 O14672 1/20 0.38
▸ MMP2 P08253 1/20 0.38
▸ MMP9 P14780 1/20 0.38
▸ MMP12 P39900 1/20 0.38
▸ MMP14 P50281 1/20 0.38
▸ ADAM8 P78325 1/20 0.38
▸ ADAM17 P78536 1/20 0.38
▸ NPY4R P50391 6/20 0.36
▸ NPY1R P25929 4/20 0.36
▸ NPY2R P49146 2/20 0.36
▸ NPY5R Q15761 2/20 0.36
▸ C3AR1 Q16581 1/20 0.35
▸ SIRT6 Q8N6T7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20385917 0.89 DPP7 (0.40) DPP4DPP8DPP9DPP7FAP
SCHEMBL23394645 0.89 DPP7 (0.40) DPP4DPP8DPP9DPP7FAP
SCHEMBL21323139 0.89 DPP4 (0.40) DPP4DPP8DPP9DPP7FAP
SCHEMBL19450715 0.89 DPP7 (0.40) DPP4DPP8DPP9DPP7FAP
SCHEMBL22848364 0.88 DPP4 (0.42) DPP4DPP8DPP9DPP7FAP
SCHEMBL28234596 0.88 DPP4 (0.42) DPP4DPP8DPP9DPP7FAP
SCHEMBL22797764 0.88 DPP4 (0.42) DPP4DPP8DPP9DPP7FAP
SCHEMBL20795868 0.88 DPP4 (0.42) DPP4DPP8DPP9DPP7FAP
SCHEMBL21137521 0.87 DPP4 (0.40) DPP4DPP8DPP9DPP7FAP
SCHEMBL6047671 0.87 C3AR1 (0.46) DPP4DPP8DPP9DPP7FAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3521314-B1 ANTIBODY-DRUG CONJUGATES AND USE THEREOF IN THERAPY MC SAF (FR) 2021-02-24 — — EP disclosed
EP-3521314-A1 NEW ANTIBODY-DRUG CONJUGATES AND USE THEREOF IN TREATMENT Université François Rabelais (FR) 2019-08-07 — — EP disclosed
Send feedback